We are live on
!
Find out more
WCBA
Weaver C. Barksdale & Associates Portfolio holdings
AUM
$105M
1-Year Est. Return
13.81%
This Fund
S&P 500
This Quarter
Est. Return
-3.24%
1 Year Est. Return
+13.81%
3 Year Est. Return
+40.08%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$104M
AUM Growth
-$6.47M
(-5.8%)
Cap. Flow
-$1.26M
Cap. Flow
% of AUM
-1.2%
Top 10 Holdings %
Top 10 Hldgs %
22.84%
Holding
65
New
3
Increased
2
Reduced
55
Closed
3
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Elevance Health
ELV
|
+$2.01M |
| 2 |
Unum
UNM
|
+$1.83M |
| 3 |
SiriusXM
SIRI
|
+$1.28M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$387K |
| 5 |
Principal Financial Group
PFG
|
+$233K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
IPG
Interpublic Group of Companies
IPG
|
+$1.56M |
| 2 |
CVS Health
CVS
|
+$1.07M |
| 3 |
Pfizer
PFE
|
+$925K |
| 4 |
Broadcom
AVGO
|
+$734K |
| 5 |
Ameriprise Financial
AMP
|
+$306K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 25.22% |
| 2 | Healthcare | 13.21% |
| 3 | Industrials | 11.88% |
| 4 | Technology | 9.53% |
| 5 | Energy | 8.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
Verizon
VZ
$196B
| $1.17M | 1.12% |
29,187
-734
| -2% | -$31K |
|
|
52
SiriusXM
SIRI
$9.61B
| $1.15M | 1.1% |
+50,309
| New | +$1.28M |
|
53
Medtronic
MDT
$116B
| $1.12M | 1.07% |
14,018
-280
| -2% | -$24.2K |
|
54
Omega Healthcare
OHI
$13.8B
| $1.11M | 1.06% |
29,207
-709
| -2% | -$28.3K |
|
55
Merck
MRK
$322B
| $1.1M | 1.05% |
11,038
-397
| -3% | -$40.9K |
|
56
Johnson & Johnson
JNJ
$626B
| $1.07M | 1.02% |
7,368
-260
| -3% | -$40.3K |
|
57
Truist Financial
TFC
$63.9B
| $996K | 0.95% |
22,933
-586
| -2% | -$26.2K |
|
58
Franklin Resources
BEN
$16.9B
| $971K | 0.93% |
47,803
-1,204
| -2% | -$25.4K |
|
59
T. Rowe Price
TROW
$24.3B
| $879K | 0.84% |
7,768
-191
| -2% | -$22.1K |
|
60
AES
AES
$10.5B
| $744K | 0.71% |
57,892
-1,456
| -2% | -$21.7K |
|
61
Cardinal Health
CAH
$56.3B
| $740K | 0.71% |
6,258
| – | – |
|
62
Cigna
CI
$72.4B
| $513K | 0.49% |
1,859
| – | – |
|
|
63
CVS Health
CVS
$120B
| – | – |
-17,007
| Closed | -$1.07M |
|
|
IPG
64
DELISTED
Interpublic Group of Companies
IPG
| – | – |
-49,439
| Closed | -$1.56M |
|
|
65
Pfizer
PFE
$152B
| – | – |
-31,961
| Closed | -$925K |
|
Similar funds
ANBOT
P
SHF
SDP
MAM
AF
EEL
BC
Weaver C. Barksdale & Associates's Q4 2024 Portfolio in Review
As of Q4 2024, Weaver C. Barksdale & Associates held 65 positions worth $104M, down 5.8% from $111M the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Weaver C. Barksdale & Associates's Q4 2024 filing shows 3 new, 2 increased, 55 reduced and 3 closed positions. Its largest new stake was Elevance Health: 4,803 shares worth $1.77M. The largest sale was Interpublic Group of Companies, an estimated $1.56M.
By sector, the portfolio is most concentrated in Financials at 25% of assets, up from 22% a quarter earlier, followed by Healthcare and Industrials.
- Weaver C. Barksdale & Associates's largest Q4 2024 buy was Elevance Health: 4,803 shares worth $1.77M.
- Weaver C. Barksdale & Associates added most to Bristol-Myers Squibb in Q4 2024, an estimated $387K increase.
- Weaver C. Barksdale & Associates's biggest Q4 2024 reduction was Broadcom, cutting an estimated $734K.
- Weaver C. Barksdale & Associates fully exited Interpublic Group of Companies in Q4 2024, selling an estimated $1.56M.
- Weaver C. Barksdale & Associates's ten largest holdings make up 23% of its $104M portfolio in Q4 2024.
- Weaver C. Barksdale & Associates opened 3 new positions and closed 3 in Q4 2024.
- Weaver C. Barksdale & Associates's portfolio value fell 5.8% quarter-over-quarter to $104M.
Based on Weaver C. Barksdale & Associates's 13F filing for Q4 2024, filed 12 Feb 2025.